A way forward for cancer prevention therapy: personalized risk assessment

// Zhenzhen Zhang 1 , Jeffrey Bien 2 , Motomi Mori 3 , 4 , Sonali Jindal 5 and Raymond Bergan 1 1 Division of Hematology/Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA 2 Division of Oncology, Stanford University, Palo Alto, California, USA 3 Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA 4 OHSU-PSU School of Public...